Cinacalcet for the treatment of secondary hyperparathyroidism (HPT) in patients non responsive to vitamin D

被引：0
|
作者：
Malberti, Fabio
Villa, Giuseppe
Colussi, Giacomo
Mingardi, Giulio
Quartagno, Rita
Limido, Aurelio
Conte, Ferruccio
Farina, Marco
Montagna, G.
Vezzoli, Giuseppe
Ravani, Pietro
机构：
[1] Ist Ospitalieri, Div Nefrol, Cremona, Italy
[2] Fdn Maugeri, Div Nefrol, Pavia, Italy
[3] Fdn Macchi, Div Nefrol, Varese, Italy
[4] Osped Riuniti Bergamo, Div Nephrol, I-24100 Bergamo, Italy
[5] IRCCS San Raffaele, Div Nefrol, Milan, Italy
[6] Osped Causa Pia Uboldo, Div Nefrol, Cernusco Sul Naviglio, Italy
[7] Osped S Antonio Abate, Div Nefrol, Gallarate, Italy
[8] Osped Maggiore Lodi, Div Nefrol, Lodi, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [31] Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism
    Urena-Torres, Pablo
    Bridges, Ian
    Christiano, Cynthia
    Cournoyer, Serge H.
    Cooper, Kerry
    Farouk, Mourad
    Kopyt, Nelson P.
    Rodriguez, Mariano
    Zehnder, Daniel
    Covic, Adrian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (05) : 1241 - 1254
  • [32] A population pharmacokinetic (PK) and pharmacodynamic (PD) analysis of cinacalcet HCl in renal-dialysis patients with secondary hyperparathyroidism (HPT).
    Wang, B
    Ludden, T
    Gonzalez, M
    Rein, P
    Harris, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P62 - P62
  • [33] Phase 3 study results demonstrate efficacy and safety of the calcimimetic cinacalcet HCI in hemodialysis patients with secondary hyperparathyroidism (HPT).
    Block, GA
    Martin, KJ
    Turner, SA
    Avram, MM
    Hercz, G
    Abu-Alfa, AK
    Coyne, DW
    Cohen, RM
    Moe, SM
    McCary, LC
    Olson, KA
    Goodman, WG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 461A - 461A
  • [34] Histology and immunohistochemistry of the parathyroid glands in renal secondary hyperparathyroidism refractory to vitamin D or cinacalcet therapy
    Vulpio, Carlo
    Bossola, Maurizio
    Di Stasio, Enrico
    Tazza, Luigi
    Silvestri, Patrizia
    Fadda, Guido
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 168 (06) : 811 - 819
  • [35] Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy
    Eandi, Mario
    Pradelli, Lorenzo
    Iannazzo, Sergio
    Chiroli, Silvia
    Pontoriero, Giuseppe
    PHARMACOECONOMICS, 2010, 28 (11) : 1041 - 1054
  • [36] Treatment With Cinacalcet of Secondary Hyperparathyroidism After Renal Transplantation
    Gomez Marques, G.
    Obrador Mulet, A.
    Vilar Gimeno, A.
    Pascual Felip, M. J.
    Alarcon Zurita, A.
    Molina Guasch, M.
    UrioL Rivera, M.
    Munar Vila, M. A.
    Losada Gonzalez, P.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) : 2139 - 2143
  • [37] Is cinacalcet a cost-effective treatment in severe secondary hyperparathyroidism in patients on hemodialysis?
    Arenas, M. D.
    Rebollo, P.
    Alvarez-Ude, F.
    Prieto, L.
    Gil, M. T.
    Malek, T.
    Moledous, A.
    Nunez, C.
    NEFROLOGIA, 2008, 28 (05): : 511 - 516
  • [38] ECONOMIC EVALUATION OF CINACALCET VERSUS STANDARD TREATMENT IN PATIENTS WITH SECONDARY HYPERPARATHYROIDISM IN MEXICO
    Arocho, R.
    Ianazzo, S.
    Rivera Hurtado, R.
    Paniagua Sierra, J. R.
    VALUE IN HEALTH, 2011, 14 (03) : A75 - A75
  • [39] Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy
    Mario Eandi
    Lorenzo Pradelli
    Sergio Iannazzo
    Silvia Chiroli
    Giuseppe Pontoriero
    PharmacoEconomics, 2010, 28 : 1041 - 1054
  • [40] Treatment Based on Cinacalcet Reduces Oxidative Stress in Hemodialysis Patients with Secondary Hyperparathyroidism
    Kuczera, Piotr
    Adamczak, Marcin
    Machnik, Grzegorz
    Okopien, Boguslaw
    Wiecek, Andrzej
    NEPHRON, 2018, 139 (04) : 286 - 292
12345